KABUL, Afghanistan — Afghanistan, whose residents have largely brushed apart the coronavirus pandemic as exaggerated or an outright hoax, is now making ready to distribute its first batch of vaccines.
A half-million doses of the AstraZeneca-Oxford vaccine, produced by an Indian producer, have been delivered to the capital, Kabul, by India on Feb. 7. However the arrival was greeted with indifference by many Afghans, who’ve rebuffed authorities warnings that the virus is a lethal public well being risk.
A budget and easy-to-store AstraZeneca-Oxford vaccine is being delivered as a part of the Covax program, a worldwide initiative to purchase and distribute vaccines to poor nations without cost or at a diminished value. On Feb. 15, the World Well being Group approved use of the vaccine, which requires two doses per individual, clearing the trail for Afghanistan to start its inoculation marketing campaign.
International trials have discovered that the vaccine supplied full safety towards extreme illness and demise. However its efficacy towards the virus variant first seen in South Africa is in query, after the vaccine failed in a small trial to stop research members from getting gentle or average Covid circumstances.
The vaccine arrives as Afghanistan is combating off a